The Venture Codex Logo

The Venture Codex

Overview

Access to safe and effective medicines and healthcare services.

Founded

1849

Deals ยท 12mo

2

Stage focus

Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical
...

Investment portfolio

47rounds
NAMEDATESIZE
CellCentric
May 2026Participated
$220 MSeries D
Syneron Bio
Dec 2025Participated
$100 MSeries A
Promise Bio
Oct 2024Participated
$8 MSeed
CytoReason
Jul 2024Participated
$80 MOther Equity
Cour Pharmaceuticals Development
Jan 2024Participated
$105 MSeries A
CellCentric
Jul 2023Led
$25 MOther Equity
Vedanta Biosciences
Apr 2023Participated
$107 MOther Equity
Ribon Therapeutics
Jan 2023Led
$25 MOther Equity
Anokion
Oct 2022Led
$35 MOther Equity
AgomAb Therapeutics
Jul 2022Led
$39 MSeries B
Dren Bio
Jun 2022Participated
$65 MSeries B
Vedanta Biosciences
Jul 2021Participated
$68 MSeries D
CellCentric
May 2026Participated
$220 MSeries D
Syneron Bio
Dec 2025Participated
$100 MSeries A
Promise Bio
Oct 2024Participated
$8 MSeed
CytoReason
Jul 2024Participated
$80 MOther Equity
Cour Pharmaceuticals Development
Jan 2024Participated
$105 MSeries A
CellCentric
Jul 2023Led
$25 MOther Equity
Vedanta Biosciences
Apr 2023Participated
$107 MOther Equity
Ribon Therapeutics
Jan 2023Led
$25 MOther Equity
Anokion
Oct 2022Led
$35 MOther Equity
AgomAb Therapeutics
Jul 2022Led
$39 MSeries B
Dren Bio
Jun 2022Participated
$65 MSeries B
Vedanta Biosciences
Jul 2021Participated
$68 MSeries D
47
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Pfizer: 47 funding rounds are recorded in the selected participation categories.All available history.
Pfizer: 47 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A211
Series B47
Series C+05
Other Equity97

Monthly Deal Activity

Pfizer: 47 deals are recorded across 202 months.All available history.
Pfizer: 47 deals are recorded across 202 months. All available history
MonthDeals
Jan '101
Feb '100
Mar '100
Apr '100
May '101
Jun '100
Jul '100
Aug '100
Sep '100
Oct '100
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '111
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '121
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '131
Nov '131
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '141
Aug '140
Sep '140
Oct '141
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '151
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '163
Feb '161
Mar '160
Apr '161
May '160
Jun '160
Jul '160
Aug '160
Sep '161
Oct '160
Nov '160
Dec '161
Jan '171
Feb '172
Mar '170
Apr '172
May '170
Jun '171
Jul '170
Aug '170
Sep '171
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '181
Jun '180
Jul '180
Aug '181
Sep '180
Oct '180
Nov '181
Dec '180
Jan '190
Feb '190
Mar '191
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '201
Jun '200
Jul '200
Aug '200
Sep '201
Oct '201
Nov '200
Dec '200
Jan '212
Feb '211
Mar '210
Apr '210
May '210
Jun '211
Jul '211
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '221
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Pfizer: Health & Life Sciences is the largest displayed sector by deal count (46 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Pfizer: Health & Life Sciences is the largest displayed sector by deal count (46 deals). All available history
SectorDeals
Health & Life Sciences46
Professional Services3
Manufacturing2
AI & Machine Learning2
Marketing & Advertising1
Enterprise Software1

Deal Size Distribution

Pfizer: 47 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Pfizer: 47 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M3
$10M-$25M8
$25M-$50M15
$50M-$100M12
$100M-$250M6
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Pfizer: United States has the largest recorded deal count among the displayed regions (31 deals).All available history.

Top 6 of 6 regions; European countries are grouped as Europe.

Pfizer: United States has the largest recorded deal count among the displayed regions (31 deals). All available history
RegionDeals
United States31
Europe11
Israel2
021391
China1
Canada1
Pfizer: 20 co-investors are shown, with Roche Venture sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Pfizer: Led accounts for 32% and participating for 68% of round participation.All available history.
Pfizer: Led accounts for 32% and participating for 68% of round participation. All available history
CategoryDeals (count)Share (%)
Led1532%
Participating3268%
Pfizer: Single-lead accounts for 80% and co-led for 20% of lead dynamics.All available history.
Pfizer: Single-lead accounts for 80% and co-led for 20% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1280%
Co-led320%

Team

Angela L Coral

Senior Manager, Partnerships & Impact Reporting, Global Health & Social Impact

Doug Lankler

General Counsel

Fady Ibrahim

Sr Principal Scientist

George Koutitas

Director Architecture, EU Digital Engagement & Machine Learning

Kathrin Jansen

Senior Vice President, Head of Vaccine Research and Development

Rachele Nestor

Oncology Account Specialist

Sonal Bhatia

Chief Medical Officer, Rare Disease

Tony Rao

Team Member